PRESS-RELEASE ·Filed Jul 14, 2026

LMAT

LeMaitre Vascular, Inc.
BEARISH
Impact 7/10
Horizondays Processed2mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▼ Bearish

The 15.7% EPS miss breaks a streak of beats and signals potential operational headwinds. Monitor the Q2 2026 earnings release on August 4 for guidance and any commentary on margin pressure or demand trends. The stock may face near-term selling pressure given the magnitude of the miss.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
LMAT ▼ -17.70% at T+20d
SHORT call ✓ call won +17.70% · α vs SPY +20.04% · entry $99.79 → $82.13
Next anchor: T+60d in 5d
Latest observation: T+53 -0.64% FF3 residual α
Entry anchored
Jul 14, 03:59 PM ET
via exchange tick
T+1d
+3.25%
call -3.25% · α -3.79%
$103.03
settled 3mo ago
T+5d
-0.98%
call +0.98% · α +0.00%
$98.81
settled 2mo ago
T+20d
-17.70%
call +17.70% · α +20.04%
$82.13
settled 7w ago
T+60d
—
call — · α —
—
in 5d

Price Chart

Loading chart...

Executive Summary

LeMaitre Vascular reported Q1 2026 EPS of $0.68, missing consensus of $0.81 by 15.7%, and revenue of $71.5M (in line with estimates). The miss is significant for a medical device company with a history of consistent beats, and the stock has historically declined on similar neutral-to-bearish reports.

Key Financial Metrics

EPS
$0.68
est $0.81 · -15.7%
Revenue
$71.5M
est $71.5M · 0.0%
Rating
miss

Key Facts

  • Q1 2026 EPS of $0.68 missed consensus of $0.81 by $0.13 (-15.7%)
  • Revenue of $71.5M was in line with consensus estimates
  • EPS miss is the largest in at least the last four quarters (prior quarters had beats of +1.5% to +8.8%)
  • Company will release Q2 2026 results on August 4, 2026, after market close

Financial Impact

EPS miss of 15.7% vs consensus; revenue in line

epsrevenue

Risk Factors

  • Further EPS misses could erode investor confidence
  • Revenue growth may slow if the miss reflects broader demand issues
  • Stock has historically underperformed following similar reports (avg T+20 alpha -9.49%)

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3327365
11 reports for LMAT
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+20▲ +15.08%May 7, 2026
Filters
Rows
Reports for LMAT — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$80.45 $82.34▲ +2.35%▲ +2.09%$78.78 (−2.08%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$99.79 $82.13▲ +17.70%▲ +20.04%$78.78 (+21.06%)
May 7, 2026
21w ago
Insider Cluster
BEARISH ★ 4/10
$107.91 $91.64▲ +15.08%▲ +18.21%$78.78 (+27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$110.22 $91.64▼ −16.86%▼ −19.64%$78.78 (−28.53%)
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$108.09 $112.71▲ +4.27%▲ +3.75%$78.78 (−27.12%)
Feb 26, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$113.43 $110.33▲ +2.73%▼ −3.67%$78.78 (+30.55%)
Showing 10 of 11

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 14, 2026